Why the study?
Large studies comparing long-term outcomes between available catheter ablation techniques in pediatric patients with AVRT or AVNRT were lacking.
Does remote magnetic navigation-guided radiofrequency ablation reduce long-term recurrence of tachyarrhythmia in pediatric patients with AVRT or AVNRT compared to manual RF or cryoablation?
Does remote magnetic navigation-guided radiofrequency ablation reduce long-term recurrence of tachyarrhythmia in pediatric patients with AVRT or AVNRT compared to manual RF or cryoablation?
Remote magnetic navigation-guided radiofrequency ablation demonstrates superior long-term efficacy and lower fluoroscopy doses compared to manual radiofrequency and cryoablation for pediatric AVRT and AVNRT.
BACKGROUND: Catheter ablation (CA) is the first-choice treatment for tachyarrhythmia in children. Currently available CA techniques differ in mechanism of catheter navigation and energy sources. There are no large studies comparing long-term outcomes between available CA techniques in a pediatric population with atrioventricular reentry tachycardia (AVRT) or atrioventricular nodal reentry tachycardia (AVNRT) mechanisms. OBJECTIVE: This study aimed to compare procedural and long-term outcomes of remote magnetic navigation-guided radiofrequency (RF) ablation (RMN), manual-guided RF ablation (MAN) and manual-guided cryoablation (CRYO). METHODS: This single-center, retrospective study included all first consecutive CA procedures for AVRT or AVNRT performed in children without structural heart disease from 2008 to 2019. Three study groups were defined by the ablation technique used: RMN, MAN or CRYO. Primary outcome was long-term recurrence of tachyarrhythmia. RESULTS: In total, we included 223 patients, aged 14 (IQR 12-16) years; weighting 56 (IQR 47-65) kilograms. In total, 108 procedures were performed using RMN, 76 using MAN and 39 using CRYO. RMN had significantly lower recurrence rates compared to MAN and CRYO at mean follow-up of 5.5 ± 2.9 years (AVRT: 4.3% versus 15.6% versus 54.5%, P < 0.001; AVNRT: 7.7% versus 8.3% versus 35.7%, P = 0.008; for RMN versus MAN versus CRYO respectively). In AVNRT ablation, RMN had significantly lower fluoroscopy doses compared to CRYO [30 (IQR 20-41) versus 45 (IQR 29-65) mGy, P = 0.040). CONCLUSION: In pediatric patients without structural heart disease who underwent their first AV(N)RT ablation, RMN has superior long-term outcomes compared to MAN and CRYO, in addition to favorable fluoroscopy doses.
No takes yet. Share an insight, caveat, or question.
Noten et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: